Task 2024 NSCOR #1/Chronic Study III: Cancer Biomarkers and Countermeasures (mixed field study)
Last Published:  07/27/17 09:48:12 AM (Central)
Short Title: 2024 Chronic Study III
Responsible HRP Element: Space Radiation
Collaborating Org(s):
Funding Status: Planned-Funded - Task expected to be within budget
Procurement Mechanism(s):
Solicited
Aims:
Aim 1: Evaluate efficacy of candidate radioprotective and chemopreventative agents using chronic, mixed field GCR exposures. 

Aim 2: Evaluate efficacy of candidate radioprotective and chemopreventative agents using SPE simulation.

Aim 3: Validate biomarker approaches for outcome prediction and surveillance using chronic, mixed field GCR and SPE exposures.

Aim 4: Validate efficacy of candidate countermeasure agents in additional model systems in compliance with FDA animal rules.


Resources (None Listed)
Mappings